← Back to Search

Corticosteroid

Mobile Application for Atopic Dermatitis

N/A

Waitlist Available

Led By Steven R Feldman, MD, PhD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosis of skin dermatitis

Age > 9

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 7

Awards & highlights

Study Summary

This trial highlights the problem of patients not taking their medications as prescribed. About half of people with chronic diseases do not follow their treatment plans, leading to high hospital costs. This issue is common in dermat

Who is the study for?

This trial is for individuals with atopic dermatitis, commonly known as eczema. It's designed to help those who struggle with following their medication regimen consistently.Check my eligibility

What is being tested?

The study is testing the effectiveness of a mobile app in improving treatment adherence compared to standard care. Participants will also be shown how to apply triamcinolone cream properly.See study design

What are the potential side effects?

While the trial focuses on app usage and demonstration, side effects may relate primarily to the use of triamcinolone cream which can include skin irritation, dryness, or infections.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with skin dermatitis.

Select...

I am older than 9 years.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 7

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 7

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 7 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Amount of Topical Medication Dispensed - Demonstration Group

Amount of Topical Medication Dispensed - Mobile Application Group

Amount of Topical Medication Dispensed - Standard of Care Group

+6 more

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Written/verbal instructions onlyExperimental Treatment1 Intervention

Standard of care written/verbal instructions only

Group II: Mobile ApplicationExperimental Treatment1 Intervention

Additional mobile application that provides instructions to apply the medication (triamcinolone cream)

Group III: DemonstrationActive Control1 Intervention

Observe a live demonstration instructing how to dispense 1 fingertip unit (FTU) of medication (triamcinolone cream) per 1% body surface area

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,243 Previous Clinical Trials

1,004,700 Total Patients Enrolled

Steven R Feldman, MD, PhDPrincipal InvestigatorWake Forest University Health Sciences

14 Previous Clinical Trials

573 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals still eligible to participate in this ongoing research?

"According to clinicaltrials.gov, this investigation is not presently open for recruitment. Initially made available on April 1st, 2024, the most recent update was on January 29th of the same year. While this particular study isn't accepting applicants currently, there are an impressive total of 247 other trials actively seeking participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Topical Treatment for Atopic Dermatitis

2024. "Topical Treatment for Atopic Dermatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06244212.

All > Atopic Dermatitis